Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Q32 Bio Inc.

Q32 Bio Inc. (QTTB) Stock Overview

Explore Q32 Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.

QTTB●NASDAQ
HealthcareBiotechnology
$16.49
$0.33(2.07%)
U.S. Market opens in 11h 43m

Q32 Bio Inc. (QTTB)

Meyka AI Score

Z

Key Financials

Market Cap210.7M
P/E Ratio5.43
EPS (TTM)$2.07
ROE0.97%
Fundamental Analysis

AI Price Forecasts

1 Month$14.66
3 Months$33.93
1 Year Target$0.00

QTTB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Q32 Bio Inc. (NASDAQ: QTTB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Q32 Bio Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of QTTB on the NASDAQ shows an RSI of 57.46, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Q32 Bio Inc.'s NASDAQ-traded stock include a P/E ratio of 5.43 and a market capitalization of 210.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of QTTB on the NASDAQ.

Price Performance (NASDAQ: QTTB)

1-Day Change
2.07%
5-Day Change
4.83%
1-Month Change
28.13%
3-Month Change
220.82%
6-Month Change
326.10%
Year-to-Date (YTD) Change
396.69%
1-Year Change
732.83%
3-Year Change
-28.43%
5-Year Change
-86.31%
All-Time (Max) Change
-95.09%

Contact Information

https://www.q32bio.com
781 999 0232
830 Winter Street, Waltham, MA, 02451

Company Facts

240 Employees
IPO DateMar 28, 2018
CountryUS
Actively Trading

Frequently Asked Questions